ebselen has been researched along with ALS - Amyotrophic Lateral Sclerosis in 4 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
McAlary, L | 2 |
Shephard, VK | 1 |
Wright, GSA | 2 |
Yerbury, JJ | 3 |
Amporndanai, K | 1 |
Rogers, M | 1 |
Watanabe, S | 1 |
Yamanaka, K | 1 |
O'Neill, PM | 2 |
Hasnain, SS | 2 |
Cashman, NR | 1 |
Capper, MJ | 1 |
Barbieri, L | 1 |
Luchinat, E | 1 |
Mercatelli, E | 1 |
Antonyuk, SV | 1 |
Banci, L | 1 |
4 other studies available for ebselen and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
A copper chaperone-mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Biomimetic Materials; Copper; Disulfides; Humans; Isoindoles; Molecul | 2022 |
Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Azoles; Betacoronavirus; Binding Sites; Cell Line, Tumor; Cr | 2020 |
Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Azoles; Body Weight; Disease Models, Animal; Humans; Isoindo | 2020 |
The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation.
Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Asthma; Azoles; Crystallography, X-Ray; Cysteine; Disul | 2018 |